ATE215949T1 - Hydroisochinolinderivate - Google Patents
HydroisochinolinderivateInfo
- Publication number
- ATE215949T1 ATE215949T1 AT94924764T AT94924764T ATE215949T1 AT E215949 T1 ATE215949 T1 AT E215949T1 AT 94924764 T AT94924764 T AT 94924764T AT 94924764 T AT94924764 T AT 94924764T AT E215949 T1 ATE215949 T1 AT E215949T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- derivatives
- sec
- nitrogen
- zero
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT93MI001788A IT1265043B1 (it) | 1993-08-06 | 1993-08-06 | Derivati di idroisochinolina |
ITMI940202A IT1274008B (it) | 1994-02-04 | 1994-02-04 | Derivati di idroisochinolina |
PCT/EP1994/002325 WO1995004734A1 (en) | 1993-08-06 | 1994-07-14 | Hydroisoquinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE215949T1 true ATE215949T1 (de) | 2002-04-15 |
Family
ID=26331034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94924764T ATE215949T1 (de) | 1993-08-06 | 1994-07-14 | Hydroisochinolinderivate |
Country Status (11)
Country | Link |
---|---|
US (1) | US5731322A (de) |
EP (1) | EP0712402B1 (de) |
JP (1) | JPH09505030A (de) |
CN (1) | CN1043641C (de) |
AT (1) | ATE215949T1 (de) |
AU (1) | AU690576B2 (de) |
CA (1) | CA2168853A1 (de) |
DE (1) | DE69430373T2 (de) |
ES (1) | ES2173921T3 (de) |
NZ (1) | NZ271338A (de) |
WO (1) | WO1995004734A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
AU2002346994B2 (en) | 2001-10-15 | 2007-09-06 | Janssen Pharmaceutica N.V. | Novel substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
CN100549004C (zh) | 2003-10-01 | 2009-10-14 | 阿得罗公司 | 螺环杂环衍生物及其应用方法 |
US7087749B2 (en) * | 2004-03-11 | 2006-08-08 | Adolor Corporation | Substituted piperidine compounds and methods of their use |
US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
EP3827747A1 (de) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharmainformatiksystem |
US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
AU2007294968A1 (en) | 2006-09-12 | 2008-03-20 | Adolor Corporation | Use of N-containing spirocompounds for the enhancement of cognitive function |
EP2063905B1 (de) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen |
US7645801B2 (en) * | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
HUE059078T2 (hu) | 2009-02-20 | 2022-10-28 | Enhanx Biopharm Inc | Glutation-alapú hatóanyagszállító rendszer |
IL295075A (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
US20100311782A1 (en) * | 2009-06-08 | 2010-12-09 | Adolor Corporation | Substituted piperidinylpropanoic acid compounds and methods of their use |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
AU2012204232A1 (en) | 2011-01-07 | 2013-06-27 | Corcept Therapeutics, Inc. | Combination steroid and glucocorticoid receptor antagonist therapy |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
EP3560493B1 (de) | 2013-11-25 | 2021-03-31 | Corcept Therapeutics Incorporated | Oktahydro-kondensierte azadecalin-glucocorticoid-rezeptor-modulatoren |
UA127409C2 (uk) | 2017-03-31 | 2023-08-16 | Корцепт Терап'Ютікс, Інк. | Модулятори глюкокортикоїдного рецептора для лікування раку шийки матки |
US11234971B2 (en) | 2018-12-19 | 2022-02-01 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
MX2021007322A (es) | 2018-12-19 | 2021-07-07 | Corcept Therapeutics Inc | Formulaciones farmaceuticas que contienen relacorilant, un compuesto de azadecalina fusionado con heteroaril-cetona. |
US11389432B2 (en) | 2018-12-19 | 2022-07-19 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
SG11202108964YA (en) | 2019-02-22 | 2021-09-29 | Corcept Therapeutics Inc | Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator |
CN110330465B (zh) * | 2019-06-28 | 2021-05-11 | 深圳市三启药物开发有限公司 | 腙酰胺类衍生物及其在制备防治脱发药物中的应用 |
AU2020400061A1 (en) | 2019-12-11 | 2022-04-14 | Corcept Therapeutics Incorporated | Methods of treating antipsychotic-induced weight gain with miricorilant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4260762A (en) * | 1979-09-10 | 1981-04-07 | Hoffmann-La Roche Inc. | Octahydro-1H-pyrrolo[2,3-g]isoquinolines |
ES2173866T3 (es) * | 1991-07-05 | 2002-11-01 | Glaxosmithkline Spa | Derivados de hidroisoquinolina. |
-
1994
- 1994-07-14 NZ NZ271338A patent/NZ271338A/en unknown
- 1994-07-14 DE DE69430373T patent/DE69430373T2/de not_active Expired - Fee Related
- 1994-07-14 ES ES94924764T patent/ES2173921T3/es not_active Expired - Lifetime
- 1994-07-14 AT AT94924764T patent/ATE215949T1/de not_active IP Right Cessation
- 1994-07-14 EP EP94924764A patent/EP0712402B1/de not_active Expired - Lifetime
- 1994-07-14 CA CA002168853A patent/CA2168853A1/en not_active Abandoned
- 1994-07-14 AU AU74937/94A patent/AU690576B2/en not_active Ceased
- 1994-07-14 WO PCT/EP1994/002325 patent/WO1995004734A1/en active IP Right Grant
- 1994-07-14 JP JP7506175A patent/JPH09505030A/ja not_active Ceased
- 1994-07-14 US US08/591,514 patent/US5731322A/en not_active Expired - Fee Related
- 1994-07-14 CN CN94193633A patent/CN1043641C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH09505030A (ja) | 1997-05-20 |
CN1132510A (zh) | 1996-10-02 |
CA2168853A1 (en) | 1995-02-16 |
WO1995004734A1 (en) | 1995-02-16 |
AU690576B2 (en) | 1998-04-30 |
AU7493794A (en) | 1995-02-28 |
NZ271338A (en) | 1998-06-26 |
DE69430373D1 (de) | 2002-05-16 |
US5731322A (en) | 1998-03-24 |
EP0712402B1 (de) | 2002-04-10 |
DE69430373T2 (de) | 2002-12-12 |
ES2173921T3 (es) | 2002-11-01 |
CN1043641C (zh) | 1999-06-16 |
EP0712402A1 (de) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69430373T2 (de) | Hydroisochinolinderivate | |
TW367327B (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use | |
DE69618231T2 (de) | TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER | |
PL326159A1 (en) | Heterocyclic fungicides | |
NZ331001A (en) | Use of an opiate K receptor agonist as an antipruritic | |
MX9705590A (es) | Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen. | |
MY102842A (en) | Calcium independent camp phosphodiesterase inhibitor antidepressant | |
NO20003133D0 (no) | Anilidderivater, fremstilling og anvendelse derav | |
ATE245636T1 (de) | Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten | |
AU2003301020A8 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
CO5031285A1 (es) | Triarilimidazoles | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
UA35557C2 (uk) | Похідні 1,2,4-оксадіазолілфеноксіалкілізоксазолу, що мають противірусну активність та фармацевтична композиція на їх основі | |
DE69507293T2 (de) | Benzamid-derivate als vasopressin-antagonisten | |
MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
TW372238B (en) | N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics | |
ES8605514A1 (es) | Procedimiento para preparar nuevas 8 a-acilaminoergolinas | |
DE3671890D1 (de) | Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen. | |
MX9709466A (es) | Medicamento para inhibir el melanoma. | |
DE69619259T2 (de) | Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase | |
TW356471B (en) | Novel carbocyclic nucleoside agents useful as selective inhibitor of proinflammatory cytokines | |
ATE37712T1 (de) | -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. | |
ATE47135T1 (de) | Antikonvulsive mittel. | |
DE69526097D1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |